Title:
NOVEL COMPOUNDS AS INHIBITORS OF PCSK9
Document Type and Number:
WIPO Patent Application WO/2023/280155
Kind Code:
A1
Abstract:
Disclosed are a compound of formula (I), wherein the variables are defined in the specification, a pharmaceutical composition containing the same, and a method and a use of the compound or composition in the treatment of a PCSK9-mediated disease such as cardiovascular disease.
Inventors:
CHENG SOAN (US)
ZHANG CHENGGANG (NZ)
ZHANG CHENGGANG (NZ)
Application Number:
PCT/CN2022/103890
Publication Date:
January 12, 2023
Filing Date:
July 05, 2022
Export Citation:
Assignee:
SHENGKE PHARMACEUTICALS JIANGSU LTD (CN)
International Classes:
C07D307/68; A61K31/341; A61K31/40; A61K31/404; A61P3/06; C07D207/34; C07D209/42
Domestic Patent References:
| WO2021143762A1 | 2021-07-22 |
Foreign References:
| CN108239073A | 2018-07-03 |
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF:
Previous Patent: INFORMATION CONFIGURATION METHOD, RELATED DEVICE AND STORAGE MEDIUM
Next Patent: MODIFIED NUCLEOSIDE OR NUCLEOTIDE
Next Patent: MODIFIED NUCLEOSIDE OR NUCLEOTIDE